Loading…
Loading the latest PSX data…
Loading the latest PSX data…
Ferozsons Laboratories Limited (FEROZ) against the KSE-100 index: performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-10
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | FEROZPharmaceuticals |
|---|---|
| danioPSX score | 40 |
| Price and size | |
| Price | Rs 362.49 |
| Today | −1.49% |
| Market cap | Rs 15.8bn |
| Traded per day | Rs 4m |
| Valuation and dividends | |
| P/E | 22.9 |
| Dividend yield | 1.6% |
| EPS (last year) | Rs 14.97 |
| Business | |
| EPS growth | +23.2% |
| Sales growth | +13.7% |
| Net margin | 4.1% |
| Returns | |
| 1 month | +10.5% |
| 3 months | −3.3% |
| 1 year | −7.1% |
| vs KSE-100, 1 year | -20.2 pts |
| Trend and risk | |
| 52-week position | 38% |
| RSI 14 | 58 |
| RS rank | 42 |
| Volatility | 41% |
| Beta | 1.05 |
| danioPSX score | |
| Value | 16 |
| Quality | 60 |
| Dividend | 27 |
| Momentum | 44 |
| Safety | 55 |
| Shariah-compliant | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener